| 18.61 -0.01 (-0.05%) | 04-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 21.74 | 1-year : | 25.4 |
| Resists | First : | 18.62 | Second : | 21.74 |
| Pivot price | 18.52  |
|||
| Supports | First : | 18.42 | Second : | 18.29 |
| MAs | MA(5) : | 18.6 |
MA(20) : | 18.5 |
| MA(100) : | 17.3 |
MA(250) : | 15.76 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 95.7 |
D(3) : | 94.9 |
| RSI | RSI(14): 60.6 |
|||
| 52-week | High : | 18.86 | Low : | 12 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ FONR ] has closed below upper band by 27.8%. Bollinger Bands are 72.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 54 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 18.64 - 18.73 | 18.73 - 18.81 |
| Low: | 18.38 - 18.48 | 18.48 - 18.56 |
| Close: | 18.46 - 18.62 | 18.62 - 18.75 |
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Thu, 09 Apr 2026
Trading the Move, Not the Narrative: (FONR) Edition - Stock Traders Daily
Thu, 09 Apr 2026
Dimensional Fund Advisors (NASDAQ: FONR) reports 315,471 shares (5.1%) - Stock Titan
Wed, 08 Apr 2026
FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequac - The National Law Review
Thu, 02 Apr 2026
FONAR Corporation (FOAA.F) stock price, news, quote and history - Yahoo Finance UK
Fri, 27 Mar 2026
Are WBD, FONR, ULY Obtaining Fair Deals for their Shareholders? - Finviz
Tue, 17 Feb 2026
FONAR Corporation Reports Q2 Fiscal 2026 Financial Results - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 6 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 12.2 (%) |
| Held by Institutions | 42 (%) |
| Shares Short | 80 (K) |
| Shares Short P.Month | 25 (K) |
| EPS | 1.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 27.01 |
| Profit Margin | 7.1 % |
| Operating Margin | 11.7 % |
| Return on Assets (ttm) | 3.1 % |
| Return on Equity (ttm) | 6 % |
| Qtrly Rev. Growth | 2.4 % |
| Gross Profit (p.s.) | 7.01 |
| Sales Per Share | 17.18 |
| EBITDA (p.s.) | 2.43 |
| Qtrly Earnings Growth | 1.1 % |
| Operating Cash Flow | 9 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | 16.18 |
| PEG Ratio | 0 |
| Price to Book value | 0.68 |
| Price to Sales | 1.08 |
| Price to Cash Flow | 12.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|